These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32059540)

  • 1. Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored.
    Gutfreund Y
    Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32059540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal consistency and compatibility of the 3Rs and 3Vs principles for project evaluation of animal research.
    Eggel M; Würbel H
    Lab Anim; 2021 Jun; 55(3):233-243. PubMed ID: 33215575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions.
    Pound P; Nicol CJ
    PLoS One; 2018; 13(3):e0193758. PubMed ID: 29590200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm-benefit analysis - what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research.
    Grimm H; Olsson IAS; Sandøe P
    Lab Anim; 2019 Feb; 53(1):17-27. PubMed ID: 29966482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.
    Eggel M; Grimm H
    Animals (Basel); 2018 Feb; 8(3):. PubMed ID: 29495562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviewing the Review: A Pilot Study of the Ethical Review Process of Animal Research in Sweden.
    Jörgensen S; Lindsjö J; Weber EM; Röcklinsberg H
    Animals (Basel); 2021 Mar; 11(3):. PubMed ID: 33807898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Road to Hell Is Paved with Good Intentions: Why Harm-Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research.
    Grimm H; Eggel M; Deplazes-Zemp A; Biller-Andorno N
    Animals (Basel); 2017 Sep; 7(9):. PubMed ID: 28892015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly-A Practical Guideline.
    Zintzsch A; Noe E; Grimm H
    Animals (Basel); 2020 May; 10(5):. PubMed ID: 32429139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3Rs and animal welfare - conflict or the way forward?
    Rusche B
    ALTEX; 2003; 20(Suppl 1):63-76. PubMed ID: 14671703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease.
    Graham ML; Prescott MJ
    Eur J Pharmacol; 2015 Jul; 759():19-29. PubMed ID: 25823812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical and Scientific Pitfalls Concerning Laboratory Research with Non-Human Primates, and Possible Solutions.
    Carvalho C; Gaspar A; Knight A; Vicente L
    Animals (Basel); 2018 Dec; 9(1):. PubMed ID: 30597951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for Addressing Harm-Benefit Analysis and Implementation in Ethical Evaluation - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 2.
    Laber K; Newcomer CE; Decelle T; Everitt JI; Guillen J; Brønstad A
    Lab Anim; 2016 Jun; 50(1 Suppl):21-42. PubMed ID: 27188276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts of Harm-Benefit Analysis of Animal Experiments - Report from the AALAS-FELASA Working Group on Harm-Benefit Analysis - Part 1.
    Brønstad A; Newcomer CE; Decelle T; Everitt JI; Guillen J; Laber K
    Lab Anim; 2016 Jun; 50(1 Suppl):1-20. PubMed ID: 27188275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement, reduction and refinement.
    Flecknell P
    ALTEX; 2002; 19(2):73-8. PubMed ID: 12098013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It's Time to Include Harm to Humans in Harm-Benefit Analysis - But How to Do It, That is the Question.
    Balls M
    Altern Lab Anim; 2021 Sep; 49(5):182-196. PubMed ID: 34836474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ethical analysis of the decision-making process in occupational health practice].
    Franco G
    Med Lav; 2005; 96(5):375-82. PubMed ID: 16711638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensation and Limits on Harm in Animal Research.
    Earl J
    Kennedy Inst Ethics J; 2022; 32(3):313-327. PubMed ID: 36341599
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.